Completed

Use of Diffusion Weighted Magnetic Resonance Imaging to Stage Gastric Adenocarcinoma Patients Preoperatively

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

diffusion weighted magnetic resonance imaging

Procedure
Who is being recruted

From 18 to 75 Years
+7 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Diagnostic Study

Early Phase 1
Interventional
Study Start: March 2013
See protocol details

Summary

Principal SponsorBezmialem Vakif University
Last updated: March 1, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: March 1, 2013

Actual date on which the first participant was enrolled.

proven endoscopic diagnosis of gastric adenocarcinoma for staging purposes, computed tomography for all patients evaluation of benign and malignant lymph nodes according to computed tomography findings and mapping of the lymph nodes to state precisely resectable patients according to computed tomography and anesthetic evaluation evaluation of benign and malignant lymph nodes according to diffusion weighted magnetic resonance imaging findings and mapping of the lymph nodes standard gastrectomy and D2 lymph node dissection mapping of the lymph nodes after taking the specimen out histopathological diagnosis of the lymph nodes and mapping comparison of the results taken from computed tomography, diffusion weighted magnetic resonance imaging and histopathological analysis

NCT01794026
Principal SponsorBezmialem Vakif University
Last updated: March 1, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

30 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Diagnostic Study

Diagnostic studies focus on improving how we detect or confirm a disease. They test new tools or techniques that could provide faster or more accurate diagnoses.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 75 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

4 inclusion criteria required to participate
application of both computed tomography and diffusion weighted magnetic resonance imaging
desire to attend the study protocol
gastric adenocarcinoma proven by endoscopic biopsy
standard gastrectomy and a D2 lymph node dissection
3 exclusion criteria prevent from participating
metastatic disease
preoperative neoadjuvant therapy
undesired reaction to attend the study protocol

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
histopathology of lymph nodes diagnosed by diffusion weighted magnetic resonance imaging

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Bezmialem Vakif University Faculty of Medicine Dept of General Surgery

Istanbul, Turkey (Türkiye)Open Bezmialem Vakif University Faculty of Medicine Dept of General Surgery in Google Maps
CompletedOne Study Center